Investigations 11.15.2017
Reimporting Cheaper Drugs Is Illegal
What we learned: Pharma’s concerns about drug safety have stalled efforts to import cheaper drugs.
What you can do: Import cheaper Canadian drugs yourself through PharmacyChecker.com.
What we learned: Pharma’s concerns about drug safety have stalled efforts to import cheaper drugs.
What you can do: Import cheaper Canadian drugs yourself through PharmacyChecker.com.
What we learned: Unlike other countries, the U.S. government cannot negotiate lower drug prices.
What you can do: Connect with AARP’s effort to allow Medicare to negotiate drug prices.
What we learned: Manufacturers find advantages in the Orphan Drug Act and intellectual property protections to keep prices high.
What you can do: Support efforts to make the regulation and pricing of drugs more transparent.
What we learned: PhRMA paid $14.3 million to think tanks, disease advocacy groups and universities. The money buys both assistance and silence.
What you can do: Call the drug industry trade group at 202-835-3400.
What we learned: In 2016 pharmaceutical and health product companies gave $62.7 million to congressional candidates – both Democrats and Republicans.
What you can do: Submit your story to Patients for Affordable Drugs to raise your voice about how high drug costs impact you.
What we learned: 1,500 of them swarmed Capitol Hill to pass the 21st Century Cures Act.
What you can do: Support efforts to make lobbying in Congress more fair and transparent.